Azitra Starts $17 Million U.S. IPO Effort (Private:AZTR)


A Fast Take On Azitra

Azitra (AZTR) has filed to boost $17.25 million in an IPO of its widespread inventory, in keeping with an F-1 registration assertion.

The biopharma agency is growing drug therapy candidates for numerous pores and skin circumstances.

Company Pipeline

Firm Pipeline (SEC)

Statement Of Operations

Assertion Of Operations (SEC)

IPO Use Of Proceeds

IPO Use Of Proceeds (SEC)